Brazilian researchers have developed an electrochemical sensor that can detect pancreatic cancer in its early stages. The device identifies the biomarker molecule CA19-9, which is associated with the disease, at low concentrations in a patient's blood. This offers a simpler, more affordable alternative to conventional tests, which are less accessible. A paper describing this work appears in ACS Omega.